| Secondary |
| Drug Use For Unknown Indication |
21.4% |
| Product Used For Unknown Indication |
12.7% |
| Renal Transplant |
11.4% |
| Non-hodgkin's Lymphoma |
10.9% |
| B-cell Lymphoma |
9.0% |
| Diffuse Large B-cell Lymphoma |
5.9% |
| Rheumatoid Arthritis |
5.1% |
| Chronic Lymphocytic Leukaemia |
3.3% |
| Anaplastic Large Cell Lymphoma T- And Null-cell Types Stage Iv |
2.5% |
| Disseminated Large Cell Lymphoma |
2.5% |
| High Grade B-cell Lymphoma Burkitt-like Lymphoma Recurrent |
2.5% |
| Hypertension |
2.5% |
| Type 2 Diabetes Mellitus |
1.6% |
| Diabetes Mellitus |
1.3% |
| Multiple Myeloma |
1.3% |
| Non-hodgkin's Lymphoma Unspecified Histology Indolent Stage Iv |
1.3% |
| Prophylaxis |
1.3% |
| Psoriasis |
1.3% |
| Atrial Fibrillation |
1.1% |
| Plasma Cell Myeloma |
1.1% |
|
| Thrombocytopenia |
13.3% |
| Neutropenia |
10.8% |
| Respiratory Failure |
9.6% |
| Stomatitis |
9.6% |
| Dermatomyositis |
4.8% |
| Psychomotor Hyperactivity |
4.8% |
| Sepsis |
4.8% |
| International Normalised Ratio Increased |
3.6% |
| Osteonecrosis |
3.6% |
| Pancytopenia |
3.6% |
| Pneumonia |
3.6% |
| Pyrexia |
3.6% |
| Renal Transplant |
3.6% |
| Renal Tubular Necrosis |
3.6% |
| Urinary Fistula |
3.6% |
| Urinary Retention |
3.6% |
| Anaemia |
2.4% |
| Bronchopneumonia |
2.4% |
| Cardiac Disorder |
2.4% |
| Diabetes Mellitus |
2.4% |
|
| Concomitant |
| Drug Use For Unknown Indication |
27.2% |
| Product Used For Unknown Indication |
19.5% |
| Rheumatoid Arthritis |
11.1% |
| Premedication |
4.9% |
| Hypertension |
4.0% |
| Prophylaxis |
4.0% |
| Non-small Cell Lung Cancer |
3.5% |
| Hiv Infection |
3.2% |
| Multiple Myeloma |
3.1% |
| Non-hodgkin's Lymphoma |
2.9% |
| Diffuse Large B-cell Lymphoma |
2.3% |
| Colitis Ulcerative |
2.2% |
| Metastases To Bone |
2.1% |
| Breast Cancer |
2.0% |
| Crohn's Disease |
1.5% |
| Prophylaxis Against Gastrointestinal Ulcer |
1.4% |
| Prostate Cancer Metastatic |
1.4% |
| Plasma Cell Myeloma |
1.3% |
| Pain |
1.2% |
| Chronic Obstructive Pulmonary Disease |
1.2% |
|
| Osteonecrosis |
10.8% |
| Osteonecrosis Of Jaw |
9.5% |
| Crohn's Disease |
7.2% |
| Pyrexia |
7.2% |
| Transaminases Increased |
7.2% |
| Pulmonary Embolism |
5.9% |
| Vomiting |
5.9% |
| Stomatitis |
5.4% |
| Thrombocytopenia |
5.4% |
| Renal Failure Acute |
5.0% |
| Syncope |
4.5% |
| Respiratory Failure |
3.6% |
| Pruritus |
3.2% |
| Toxic Skin Eruption |
3.2% |
| Cerebral Haemorrhage |
2.7% |
| Intestinal Obstruction |
2.7% |
| Loss Of Consciousness |
2.7% |
| Lung Infection |
2.7% |
| Oral Lichen Planus |
2.7% |
| Sepsis |
2.7% |
|
| Interacting |
| Product Used For Unknown Indication |
72.7% |
| Chronic Obstructive Pulmonary Disease |
9.1% |
| Pain In Extremity |
9.1% |
| Prophylaxis |
9.1% |
|
|
